Retardation of metastatic tumor growth after immunization with metastasis-specific monoclonal antibodies

Area of Science:

• Immunology
• Oncology
• Cancer Research

Background:

• Metastatic spread of rat adenocarcinoma (BSp73ASML) is a complex process.
• Murine monoclonal antibodies (MAbs) are tools to investigate tumor-associated antigens.
• Understanding MAb interactions with tumor cells and host immune responses is crucial for cancer therapy.

Purpose of the Study:

• To evaluate the influence of four MAbs against BSp73ASML on metastatic spread.
• To compare MAb effects with their in vivo binding and induced humoral anti-MAb responses.
• To investigate the role of anti-idiotypic (ID) antibodies, especially internal image types, in modulating metastasis.

Main Methods:

• Administration of four MAbs targeting BSp73ASML in a rat model.
• Assessment of MAb binding to tumor cells in vivo.
• Evaluation of humoral anti-MAb responses, including isotype- and idiotype-specific antibodies.
• Monitoring of metastatic growth and animal survival.

Main Results:

• All four MAbs transiently inhibited metastatic growth.
• Only one MAb (4.4ASML) significantly prolonged survival.
• One MAb (1.1ASML), targeting a CD44 variant, initially retarded then accelerated metastasis.
• Metastatic retardation correlated with anti-MAb responses, but internal image anti-1.1ASML antibodies accelerated spread.

Conclusions:

• MAb-mediated inhibition of metastasis may involve epitope blockade and induction of anti-mouse immunoglobulin (Ig) responses.
• The anti-mouse Ig response, whether isotype- or idiotype-specific, can influence metastatic progression.
• Internal image anti-idiotypic antibodies can paradoxically promote metastasis.